Windtree Therapeutics, Inc.

WINT Healthcare Biotechnology

In the quarter to September 2025, EPS grew 99.5% and free cash flow grew 1.12%, each against the same quarter a year earlier.

0.00 0.00 NaN
Market cap
$2.4M
P/E
0.0×
Fwd P/E
−2.5×
Dividend yield
—
F-score
5/9
Altman Z
−7.03
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Total current assets
2.57 5.38 7.38 23.49 18.12 23.86 25.65 2.24 7.19
Total non-current assets
25.30 27.03 30.58 51.30 94.77 95.11 93.75 1.11 2.51
Total Assets
27.88 32.41 37.95 74.79 112.89 118.98 119.40 3.35 9.70
Total current liabilities
5.72 4.00 2.46 4.92 6.13 7.82 20.63 11.76 13.39
Total non-current liabilities
12.16 25.02 25.49 27.99 37.20 36.22 30.65 15.51 25.14
Total liabilities
17.88 29.02 27.94 32.91 43.33 44.04 51.28 27.27 38.53
Common Equity (Total)
10.00 3.39 10.01 41.88 69.55 74.94 68.11 (23.92) (28.83)
Shareholders Equity (Total)
10.00 3.39 10.01 41.88 69.55 74.94 68.11 (23.92) (28.83)
Total Debt
0.96 15.23 15.25 15.29 17.78 19.77 22.97 15.00 25.00

Show all line items

In millions of $ except per-share values · columns are period end dates